Who are the key players in North America Blood Group Typing Market industry?

The top five players in the North America Blood Group Typing Market include Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostics, and Abbott Laboratories. These companies offer advanced solutions, drive innovation and regulatory approvals, and maintain strong distribution networks, making them leaders in blood group typing technologies across the region.

What is the North America Blood Group Typing Market growth?

The North America Blood Group Typing Market is witnessing steady growth, with rising adoption of molecular typing techniques and automation. In 2023, Bio-Rad Laboratories launched new reagents and automation systems, contributing significantly to market expansion, driven by increasing demand for safe transfusions and organ transplants.

Which segment accounted for the largest North America Blood Group Typing Market share?

The largest share is held by the transfusion medicine application segment. Hospitals and blood banks increasingly utilize blood group typing solutions for accurate pre-transfusion compatibility testing, minimizing risks associated with transfusions and optimizing patient outcomes, which boosts demand for sophisticated blood grouping systems.

What are the factors driving the North America Blood Group Typing Market?

Key driving factors include rising cases of chronic diseases, road accidents, and increased surgical procedures, escalating the demand for blood transfusions. For example, Grifols' investments in expanding diagnostic facilities and launching new compatible assays have supported market growth through enhanced efficiency and accuracy.

Which type accounted for the largest North America Blood Group Typing Market share?

The reagent segment holds the largest market share in North America. Widespread use of advanced reagents for blood group antigen detection and compatibility testing in clinical laboratories and hospitals contributes to this dominance, supported by continuous innovations from leading manufacturers like Ortho Clinical Diagnostics.

Home Healthcare

North America Blood Group Typing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Blood Group Typing Market
Brand: Bussiness Insights

North America Blood Group Typing Market: by Type (ABO, Rh, Kell, Duffy, Kidd, MNS), Application (Antibody Screening, Antigen Typing, Cross-matching, Prenatal Testing, Transfusion Medicine, Research), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors, Hospitals, Clinics), Technology (PCR-based, Microarray, Massively Parallel Sequencing, Assay-based, Microfluidics, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20373 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample

North America Blood Group Typing Market Analysis (2020–2035)

The North America Blood Group Typing Market is witnessing accelerated growth, driven by advancements in laboratory automation, rising demand for safe blood transfusion, and increasing prevalence of chronic diseases. Growing awareness regarding blood compatibility, strict regulatory protocols, and technological innovation are shaping the competitive landscape. With several global players introducing innovative molecular-based typing solutions, the market is expected to achieve significant market size by 2035, underpinned by robust adoption across hospitals, clinics, and diagnostic centers.

Latest Market Dynamics

Key Drivers

Rising prevalence of chronic and infectious diseases that require frequent blood transfusions is fueling demand for accurate and rapid blood group typing. For example, Danaher Corporation expanded its molecular diagnostics portfolio in mid-2024 with enhanced genotyping solutions tailored for North American healthcare facilities.

Adoption of digital and automated blood group typing solutions is accelerating as hospitals seek to minimize human errors and shorten turnaround times. In June 2024, Grifols, S.A. announced North American pilot projects using cloud-based connectivity in laboratory workflows.
A surge in personalized medicine and precision transfusion approaches is driving collaboration between diagnostic firms and healthcare providers. Ortho Clinical Diagnostics, in August 2024, rolled out a partner program to support genotyping-based prenatal screening efforts.

The expanding network and modernization of blood banks represent a major opportunity, with sustained investments in infrastructure and AI-enabled matching protocols. In July 2024, Immucor, Inc. launched AI-compatible reagents facilitating rapid blood compatibility checks across new donor centers.
Increasing government funding and favorable regulatory reforms are encouraging adoption of next-generation assays. Quotient Limited secured approval for their advanced testing panel in Canada in September 2024, addressing emergent challenges in emergency medicine.

Stringent regulatory requirements and long validation cycles for novel blood typing products continue to delay market entry, even for established players. Companies like Novacyt Group reported in June 2024 that regulatory harmonization in North America remains slow.
Shortage of skilled laboratory professionals to handle advanced blood group typing technologies can hinder smooth technology adoption, especially in smaller healthcare settings, as highlighted by Beckman Coulter’s industry survey in August 2024.

High equipment costs and maintenance outlay for state-of-the-art automated typing systems limit access for smaller labs and clinics. Tulip Diagnostics (P) Ltd. cited in July 2024 that budget constraints are restricting uptake in medium and small-sized facilities.
Data privacy and cybersecurity risks associated with moving towards cloud-enabled and AI-powered blood group typing are emerging concerns. Rapid Labs stressed the need for robust digital infrastructure in its September 2024 findings.

In 2025, the ABO blood group type commands the largest share of the North America Blood Group Typing Market, reflecting its critical role in transfusion safety protocols and universal compatibility screening. Rh typing remains vital, especially for maternal-fetal medicine, while specialized groups such as Kell, Duffy, Kidd, and MNS account for smaller but essential segments in cases of rare transfusion needs and research applications. The dominance of ABO and Rh underscores their clinical significance and frequent usage in diagnostics and clinical labs.

Antibody screening is the leading application segment in 2025, accounting for the highest market share as hospitals and transfusion centers prioritize patient safety through pre-transfusion compatibility assessments. Antigen typing is also significant, driven by growing use in prenatal and transplant medicine. Cross-matching, critical in emergency and surgical settings, along with prenatal testing and research, make up the remaining proportion. The evolving landscape points to strategic investments in broadening the scope of blood typing beyond routine transfusion into preventive and personalized medicine.

The North America Blood Group Typing Market exhibits consistent revenue growth from 2020 through 2035, with an estimated market size of 970 million USD by 2025. This positive trajectory is driven by technological advancements, greater automation in laboratories, and increasing demand for diagnostic testing across healthcare settings. Key stakeholders are investing in expanding their blood typing platforms’ capabilities in line with clinical and research needs, resulting in a favorable market outlook.

The year-on-year growth rate for the North American Blood Group Typing Market remains robust between 2020 and 2035, peaking at 8.5% in 2025 before moderating slightly as the market matures. Growth accelerates in early years due to new technology rollouts and higher testing volumes, then stabilizes as innovation adoption normalizes. Consistent investment in R&D and digital transformation will sustain above-industry-average growth rates over the decade.

The United States dominates the North America Blood Group Typing Market in 2025, representing 68% of the regional value, thanks to a highly developed healthcare system and widespread adoption of advanced diagnostics. Canada holds a significant share as well, attributed to supportive government initiatives for safe blood transfusions. Mexico, while smaller, is experiencing rapid growth due to infrastructure modernization and public-private partnerships. This regional breakdown highlights the importance of tailored strategies for each national market.

Top players control a significant portion of the blood group typing market, with Bio-Rad Laboratories, Grifols, S.A., and Ortho Clinical Diagnostics leading at a combined 54%. Immucor, Inc. and Beckman Coulter follow with strong portfolios and regional reach. Smaller and specialized firms collectively account for 37%, indicating space for innovation and partnerships. The competitive landscape is marked by technology leadership, international reach, and comprehensive product offerings.

Hospitals represent the largest share of market buyers in 2025, accounting for 49% due to their high-volume and acute care requirements. Clinics and diagnostic centers follow, as outpatient and preventive care fuel routine and specialized blood group typing demands. Direct procurement by blood banks, research institutions, and public agencies forms the remainder, underlining the market’s broad application scope across diverse stakeholder groups.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	970
Regions	United States, Canada, Mexico
Segments	By Type (ABO, Rh, Kell, Duffy, Kidd, MNS), By Application (Antibody Screening, Antigen Typing, Cross-matching, Prenatal Testing, Transfusion Medicine, Research), By Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors, Hospitals, Clinics), By Technology (PCR-based, Microarray, Massively Parallel Sequencing, Assay-based, Microfluidics, Others), By Organization Size (Small, Medium, Large)
Players	Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor, Inc., Ortho Clinical Diagnostics, Quotient Limited, Danaher Corporation, Beckman Coulter, Inc., Novacyt Group, BAG Health Care GmbH, Merck KGaA, Agena Bioscience, Inc., Rapid Labs, Tulip Diagnostics (P) Ltd., Day Medical S.A., DIAGAST

August 2024: Ortho Clinical Diagnostics launched a new high-throughput genotyping platform in major US hospital networks, furthering digital integration in transfusion medicine.
July 2024: Immucor, Inc. introduced an AI-enabled blood compatibility reagent system across multiple Canadian centers.
June 2024: Grifols, S.A. completed a successful pilot of cloud-linked laboratory analyzers, accelerating remote diagnostic services and data management.
September 2024: Quotient Limited secured Health Canada approval for its multiplexed blood group antigen detection panel.
July 2024: Beckman Coulter announced enhancements in customer support and training infrastructure for advanced typing automation in Mexico.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Blood Group Typing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Blood Group Typing Market Analysis (2020–2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type, 2025

Market Share by Applications, 2025

Market Revenue (USD Million), 2020-2035

Market Year-on-Year Growth (%), 2020-2035

Market Share by Region, 2025

Market Players Share, 2025

Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports